Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
Suministro de diferentes principios activos distribuidos en exclusividad por el laboratorio Sanofi Aventis, S.A.
Reference number: GPNSU 2020-5-FAR
II.1.2)Main CPV code
33600000 Pharmaceutical products
II.1.3)Type of contract
Supplies
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
Main site or place of performance:
Servicio de Farmacia del Hospital Universitario Puerta de Hierro Majadahonda, Calle Joaquin Rodrigo, 2, 28222 Majadahonda.
II.2.4)Description of the procurement at the time of conclusion of the
contract:
Suministro de diferentes principios activos distribuidos en exclusividad por el laboratorio Sanofi Aventis, S.A.
II.2.7)Duration of the contract, framework agreement, dynamic purchasing system or
concession
Duration in months: 24
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
Section V: Award of contract/concession
Contract No: GPNSU 2020-5-FAR
V.2)Award of contract/concession
V.2.1)Date of conclusion of the contract/concession award decision:
30/06/2020
V.2.2)Information about tenders
The contract/concession has been awarded to a group of economic operators: no
V.2.3)Name and address of the contractor/concessionaire
Official name: SANOFI AVENTIS S.A.
National registration number: A08163586
Town: Madrid
NUTS code: ES300 Madrid
Country: Spain
The contractor/concessionaire is an SME: no
V.2.4)Information on value of the contract/lot/concession (at the time of conclusion
of the contract;excluding VAT)
Total value of the procurement: 1 073 266.50 EUR
Section VI: Complementary information
VI.3)Additional information:
VI.4)Procedures for review
VI.4.1)Review body
Official name: JUZGADOS DE LO CONTENCIOSO-ADMINISTRATIVO
Postal address: Gran Vía 19 y 52
Town: MADRID
Postal code: 28013
Country: Spain
VI.4.4)Service from which information about the review procedure may be
obtained
Official name: Hospital Universitario Puerta de Hierro de Majadahonda
Postal address: C/ Joaquín Rodrigo, 2
Town: Majadahonda (Madrid)
Postal code: 28222
Country: Spain
Telephone: +34 911916000
Fax: +34 913730535
VI.5)Date of dispatch of this notice:
25/09/2023
Section VII: Modifications to the contract/concession
VII.1)Description of the procurement after the modifications
VII.1.1)Main CPV code
33600000 Pharmaceutical products
VII.1.2)Additional CPV code(s)
VII.1.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
Main site or place of performance:
Servicio de Farmacia del Hospital Universitario Puerta de Hierro Majadahonda, Calle Joaquin Rodrigo, 2, 28222 Majadahonda (Madrid)
VII.1.4)Description of the procurement:
Suministro de diferentes principios activos distribuidos en exclusividad por el laboratorio Sanofi Aventis, S.A.,
VII.1.5)Duration of the contract, framework agreement, dynamic purchasing system or
concession
Duration in months: 24
VII.1.6)Information on value of the contract/lot/concession (excluding VAT)
Total value of the contract/lot/concession: 1 073 266.50 EUR
VII.1.7)Name and address of the contractor/concessionaire
Official name: SANOFI AVENTIS S.A.,
National registration number: A-08163586
Town: Madrid
NUTS code: ES300 Madrid
Country: Spain
The contractor/concessionaire is an SME: no
VII.2)Information about modifications
VII.2.1)Description of the modifications
Nature and extent of the modifications (with indication of possible earlier changes to the contract):
Modificación en el precio del medicamento TERIFLUNOMIDA 14 MG 28 COMP , como consecuencia de la modificación del PVL financiado del medicamento, debido a la Resolución de
revisión del precio industrial máximo, dictada por la Dirección General de Cartera Común de Servicios del Sistema Nacional de Salud y Farmacia (Ministerio de Sanidad).
VII.2.2)Reasons for modification
Need for modification brought about by circumstances which a diligent contracting authority/entity could not foresee (Art. 43(1)(c) of Directive 2014/23/EU, Art. 72(1)(c) of Directive
2014/24/EU, Art. 89(1)(c) of Directive 2014/25/EU)
Description of the circumstances which rendered the modification necessary and explanation of the unforeseen nature of these circumstances:
Modificación en el precio del medicamento TERIFLUNOMIDA 14 MG 28 COMP como consecuencia de la modificación del PVL financiado del medicamento, debido a la Resolución de revisión
del precio industrial máximo, dictada por la Dirección General de Cartera Común de Servicios del Sistema Nacional de Salud y Farmacia (Ministerio de Sanidad).
VII.2.3)Increase in price
Updated total contract value before the modifications (taking into account possible earlier contract modifications and price adaptions and, in the case of Directive 2014/23/EU,
average inflation in the Member State concerned)
Value excluding VAT: 1 073 266.50 EUR
Total contract value after the modifications
Value excluding VAT: 1 066 475.92 EUR